Technology
Health
Biotechnology

Athersys

8,253

$2.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.00 (+0.06%) As of 1:57 PM EDT today
+$0.00 (+0.06%) Today

Why Robinhood?

You can buy or sell Athersys and other stocks, options, ETFs, and crypto commission-free!

About ATHX

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. Read More The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

CEO
Gil van Bokkelen
Employees
83
Headquarters
Cleveland, Ohio
Founded
1995
Market Cap
465.36M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.30M
High Today
$2.88
Low Today
$2.50
Open Price
$2.80
Volume
4.01M
52 Week High
$4.38
52 Week Low
$1.13

Collections

Technology
Health
Biotechnology
US
North America

ATHX News

ReutersApr 1

Edited Transcript of ATHX earnings conference call or presentation 16-Mar-20 8:30pm GMT

Q4 2019 Athersys Inc Earnings Call Cleveland Apr 1, 2020 (Thomson StreetEvents) -- Edited Transcript of Athersys Inc earnings conference call or presentation M
184

ATHX Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, After Hours

People Also Bought

Sangamo Therapeutics

7,470

$6.91

+1.99%

Sangamo Therapeutics

7,470

$6.91

+1.99%

Verastem

16,515

$2.85

+7.55%

TransEnterix

6,187

$0.3399

-0.03%

22nd Century Group

50,096

$0.6844

-0.81%

You May Also Like

CURE
OXLC
PACK+
FLQM
BEST
LVHE
IWS
HEAR
DLNG
ELC
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ATHX

Market Price$2.82
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Athersys stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up